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main a major cause of illness and death in
South Africa. The medical infrastructure is
good in major cities, primary health care is
expanding in rural areas, and modern
diagnostic facilities are reasonably widely
available. Urban areas have a mixture of
infectious disease problems encountered in
developing as well as industrialized countries,
and in the tropical environment of the
northeast, malaria and other vector-borne
diseases persist.
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Emerging Infectious Disease Surveillance
National surveillance of emerging infections
in South Africa is in its infancy. A number of
infectious diseases are notifiable, but no formal
laboratory-based surveillance system is in place
to confirm diagnoses or to subtype microorgan-
isms for epidemiology purposes. I have
summarized infectious disease trends in South
Africa, with special emphasis on the antimicro-
bial resistance patterns of locally circulating
microorganisms.
Bacterial Diseases
Streptococcus pneumoniae
Fully resistant and multiple-drug resistant
pneumococci were discovered in South Africa in
1978. The pattern of emergence of pneumococcal
resistance in South Africa has been somewhat
different from that observed in Western Europe
(and more recently in the United States). In
those countries, the emergence of resistance was
explosive and associated with a limited number
of clones, particularly of serotype 23F and 6B,
which are associated with multidrug resistance
and high-level penicillin resistance. The highly
resistant strains initially isolated in South Africa
belonged largely to serotype 19A and for some as
yet unexplained reason, remain rare. Antimicro-
bial resistance to penicillin in the pneumococcus
in South Africa has reached very high levels
(approximately 45% in young children), but most
of this resistance is caused by a large number of
intermediately penicillin-resistant strains rather
than a limited number of clones found
internationally. Antibiotic resistance differs in
the public versus private health-care sectors of
South Africa. The most important difference may
be the relative scarcity of macrolide resistance
among strains of pneumococci in public
hospitals, where these drugs are less often used.
Recently, the incidence of pneumococcal disease
in both adults and children has doubled as a
result of the increased incidence of HIV
infection. HIV infection is specifically associ-
ated with antibiotic resistance and with
childhood serotypes of the pneumococcus (6A,
6B, 9V, 14, 19F, 19A, 23F).
Haemophilus influenzae
In contrast to the United States and Western
Europe, South Africa has a low incidence of
betalactamase-producing H. influenzae (±10%).
The reason for the contrast between the low
incidence of betalactamase-producing H. influenzae
and the high incidence of penicillin resistance in
the pneumococcus is not known.
Neisseria meningitidis
Over the past few years, the distribution of
meningococcal serogroups has been fairly even
between groups A, B, and C. An epidemic in Cape
Town of group B in the 1980s provided an
opportunity to attempt to use an outer
membrane protein vaccine, but the epidemic
ceased before enough cases could be enrolled in
the vaccine trial. An epidemic of group A
meningococcal meningitis is ongoing in the
countries immediately to the north of South
Africa, particularly in Mozambique, and an
increasing number of group A strains are being
identified, largely in adult refugees from
Mozambique. These group A strains have been
typed by the World Health Organization
Meningococcal Reference Center in Oslo,
Norway, and represent a unique South African
clone. The epidemic clone associated with the Haj
(III-1) in the 1980s was, however, discovered for
the first time in South Africa in 1997.
Staphylococcus aureus
The incidence of methicillin-resistant S.
aureus  in South Africa is alarming, with up to
50% of nosocomial isolates being methicillin-
resistant. No vancomycin-intermediate S. aureus
strains as have been reported in the United
States and Japan have been identified in
South Africa to date. The incidence of
methicillin resistance among S. epidermidis
strains in hospitals is, as expected, even
higher.
Enterococcus
The first strains of enterococci resistant to
vancomycin (VRE) and teicoplanin, which were
due to the presence of the van A resistance gene,
were described in South Africa only in 1996.
These strains were likely imported. The
incidence of VRE in South Africa remains low but
is expected to increase.
Diarrheal Pathogens
Endogenous transmission of cholera has not
been observed in South Africa for the past
decade. Epidemics of cholera have occurred in
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Mozambique, and a number of imported cases
have been identified each summer in South
Africa. The potential for an epidemic in rural
areas with poor sanitation and contaminated
water exists. Shigella dysenteriae type I
producing Shiga toxin and associated with
hemolytic uremic syndrome was first identified
in an epidemic in adults on the South African/
Mozambican/Swaziland border in 1993. Subse-
quently, the same strain has become quite
common among children and adults, particularly
in KwaZulu-Natal province, and has spread
down the east coast to the western Cape. Disease
in adults as well as children suggests that this
strain has not been endemic in South Africa, at
least during the past generation. The strains are
resistant to ampicillin and cotrimoxazole but are
generally susceptible to nalidixic acid and the
fluoroquinolones. Occasional imports of
multidrug-resistant typhoid have been identified
in KwaZulu-Natal, where there is a large
Indian community; these strains likely come
from Southeast Asia.
Nosocomial Infections
Extended spectrum betalactamases are
endemic particularly among Klebsiella species in
intensive-care units throughout the country.
Gram-negative bacteria producing chromosoma-
lly mediated Beta-lactamase are common in all of
these settings and Acinetobacter-related prob-
lems abound in most intensive-care units.
Tuberculosis (TB)
The incidence of TB is increasing in parallel
with the HIV epidemic in South Africa. Multiple-
drug resistance remains <5% and is commonly
associated with noncompliance to drug regimens.
Plague
Low levels of endemic plague are present in
rural South Africa, but the last epidemic was in
Namibia in the 1980s.
Viral Diseases
HIV infection was not apparent in South
Africa until around 1988 when endogenous cases
began to emerge. The first reported cases
occurred predominantly in homosexual men who
had sexual contacts in the United States; in one
early case, the patient presumably had
heterosexual contact with a sex worker in
Central Africa when the disease was first
discovered there. The incidence of HIV infection
among pregnant African women in South Africa
in 1990 was 0.4%. The number of infected
persons has doubled at approximately 9-month
intervals until now when approximately 20% of
adult African men and women are infected in the
northern and eastern parts of the country. This
number declines to less than 10% in the south,
but HIV, although delayed with reference to the
rest of Africa, has had and will have a staggering
impact on emerging infectious diseases in South
Africa. No specific diseases peculiar to South
Africa have been found to be associated with HIV
infection; major opportunistic infections include
TB, cryptococcal disease, cytomegalovirus infec-
tions, bacterial diseases such as pneumococcal or
salmonella bacteremia, and toxoplasmosis.
Viral Hemorrhagic Fevers
A case of Marburg fever was identified in the
1970s in a tourist visiting several African
countries to the north of South Africa;
nosocomial transmission to two persons was
identified at that time. One case of nosocomial
transmission of Ebola has been reported (the
patient with the index case was flown down to
South Africa from Gabon); however, no endemic
transmission of Ebola virus occurs in South
Africa. That the nosocomial transmission of
Ebola virus was limited to a single person despite
the fact that the diagnosis of the index case was
not made until a number of weeks after the
patient entered the country is a tribute to the
standard of medical care in South Africa. Congo
Crimean hemorrhagic fever is endemic in
southern Africa, but as the vector tick rarely
bites humans, not many human cases have
been found. Epidemics have been associated
with infections in rural communities particu-
larly of farmers and workers who slaughtered
infected cattle. An epidemic among ostriches
occurred in 1997.
Parasitic Diseases
Malaria remains a serious systemic disease
in South Africa. The disease is endemic in the
northern and eastern parts of the country where
the climate is tropical. After many years of
spraying huts with DDT, malaria became rare,
but the interruption of the program because of
war in the 1970s and 1980s in Mozambique and
Zimbabwe (and the development of drug
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which reduced the acceptability of the program)
has led to a rapid resurgence of malaria.
Chloroquine-resistant strains, which were
rare in the 1980s, are now common, although
quinine-resistant strains have not yet been
demonstrated.  Schistosoma haematobium and
S. mansoni are endemic in rivers along the
eastern part of the country and pose a health
risk to nonimmune visitors.
Fungi
Cryptococcus neoformans var gattii and var
neoformans represent an increasing fraction of
cerebrospinal fluid isolates in South Africa
because of the HIV epidemic.
Further Reading
Additional information on emerging infec-
tious diseases in South Africa is available from
the South African Virus Laboratories Surveil-
lance Bulletin, which is  published by the
National Institute for Virology (Private Bag X4,
Sandringham, 2131 Johannesburg, South Africa);
data can be obtained from the South African
Institute for Medical Research Annual Reports
(P.O. Box 1038, Johannesburg 2000, South
Africa); national antimicrobial susceptibility
data are published in the South African
Medical Journal by the Antibiotic Study Group
of South Africa; and clinically based notifiable
diseases are reported to the Department of
Health, which produces a free journal called
Epidemiological Comments (The Director
General, Department of Health, Private Bag
X828, Pretoria, 0001, South Africa.) The final
source of information on emerging infectious
diseases in South Africa, aside from the
specific reports that would appear in any
international journal is the Proceedings of the
Annual Meeting of the Infectious Diseases
Society of Southern Africa (membership and
meeting information, Dr. Lucille Blumberg, e-
mail: lucilleb@mail.saimr.wits.ac.za).
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